HB 2716 – Oregon
Status: Inactive / DeadYear Introduced: 2023
Link: https://olis.oregonlegislature.gov/liz/2023R1/Measures/Overview/HB2716
Prohibits specified practices by insurers and pharmacy benefit managers in reimbursing cost of prescription drugs. May not discriminate against a 340B pharmacy in a manner that prevents or interferes with an enrollee’s choice to receive drugs from the pharmacy by reimbursing a 340B pharmacy less than any other network pharmacy or imposing a fee, charge-back or other adjustment on a claim for reimbursement based on a pharmacy’s status as a 340B pharmacy.
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found